LYNK Pharmaceuticals
Hangzhou
About LYNK Pharmaceuticals
LYNK Pharmaceuticals is a biotech company focusing on the discovery and development of novel medicines to treat oncology, immunology, and inflammatory diseases. The company was founded in 2018 and is headquartered in Hangzhou, Zhejiang, China.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $124.8M
- Funding stage: Late Stage Venture
- Last round: Series C (Sep 2023)
- Website: en.lynkpharma.com
- Phone: +86 0571-8771117
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/lynk-pharmaceuticals-50781 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.